Associations between Systemic Sclerosis and Thyroid Diseases

被引:18
作者
Fallahi, Poupak [1 ]
Ruffilli, Ilaria [1 ]
Giuggioli, Dilia [2 ]
Colaci, Michele [2 ]
Ferrari, Silvia Martina [1 ]
Antonelli, Alessandro [1 ]
Ferri, Clodoveo [2 ]
机构
[1] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy
[2] Univ Modena & Reggio Emilia, Dept Med Surg Maternal Pediat & Adult Sci, Modena, Italy
关键词
systemic sclerosis; autoimmune thyroiditis; hypothyroidism; Graves' disease; thyroid cancer; antithyroperoxidase antibodies; antithyroglobulin antibodies; CXCL10; OF-THE-LITERATURE; PULMONARY ARTERIAL-HYPERTENSION; AUTOIMMUNE-THYROIDITIS; ANTITHYROID ANTIBODIES; SCLERODERMA; DYSFUNCTION; DISORDERS; AUTOANTIBODIES; PREVALENCE; EXPERIENCE;
D O I
10.3389/fendo.2017.00266
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have reviewed scientific literature about the association of systemic sclerosis (SSc) and thyroid disorders. A high incidence, and prevalence, of new cases of autoimmune thyroiditis (AT) and/or hypothyroidism have been shown in sclerodermic patients (overall in the female gender). An association among a Th1 immune-predominance, low vitamin D levels, and AT have been also shown in SSc patients. Cases of Graves' disease (GD) have been described in SSc patients, too, according with the higher prevalence of thyroid autoimmunity. It has been also shown a higher prevalence of papillary thyroid cancer (PTC), in association with AT, in SSc patients. However, in order to confirm results about GD and thyroid cancer, studies in larger number of patients with SSc are needed. During the follow-up of SSc patients it would be appropriate to monitor carefully their thyroid status. The abovementioned data strongly suggest a periodic thyroid function follow-up in female SSc patients [showing a borderline high (although in the normal range) thyroid-stimulating hormone level, antithyroid peroxidase antibody positivity, and a small thyroid with a hypoechoic pattern], and, when necessary, appropriate treatments. In conclusion, most of the studies show an association among SSc, AT, and hypothyroidism, such as an increased prevalence of TC overall in SSc patients with AT. Only few cases of GD have been also described in SSc.
引用
收藏
页数:6
相关论文
共 44 条
[1]   PRELIMINARY CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC-SCLEROSIS (SCLERODERMA) [J].
不详 .
ARTHRITIS AND RHEUMATISM, 1980, 23 (05) :581-590
[2]   CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis -: a longitudinal study [J].
Antonelli, A. ;
Ferri, C. ;
Fallahi, P. ;
Ferrari, S. M. ;
Giuggioli, D. ;
Colaci, M. ;
Manfredi, A. ;
Frascerra, S. ;
Franzoni, F. ;
Galetta, F. ;
Ferrannini, E. .
RHEUMATOLOGY, 2008, 47 (01) :45-49
[3]  
Antonelli A, 2008, J RHEUMATOL, V35, P1809
[4]   Clinical and subclinical autoimmune thyroid disorders in systemic sclerosis [J].
Antonelli, Alessandro ;
Ferri, Clodoveo ;
Fallahi, Poupak ;
Cazzato, Massimiliano ;
Ferrari, Silvia Martina ;
Sebastiani, Marco ;
Ferrannini, Ele .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2007, 156 (04) :431-437
[5]   Increased risk of papillary thyroid cancer in systemic sclerosis associated with autoimmune thyroiditis [J].
Antonelli, Alessandro ;
Ferri, Clodoveo ;
Ferrari, Silvia Martina ;
Di Domenicantonio, Andrea ;
Giuggioli, Dilia ;
Galleri, David ;
Miccoli, Paolo ;
Fallahi, Poupak .
RHEUMATOLOGY, 2016, 55 (03) :480-484
[6]   Autoimmune thyroid disorders [J].
Antonelli, Alessandro ;
Ferrari, Silvia Martina ;
Corrado, Alda ;
Di Domenicantonio, Andrea ;
Fallahi, Poupak .
AUTOIMMUNITY REVIEWS, 2015, 14 (02) :174-180
[7]   Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases [J].
Antonelli, Alessandro ;
Ferrari, Silvia Martina ;
Giuggioli, Dilia ;
Ferrannini, Ele ;
Ferri, Clodoveo ;
Fallahi, Poupak .
AUTOIMMUNITY REVIEWS, 2014, 13 (03) :272-280
[8]   Incidence of Thyroid Disorders in Systemic Sclerosis: Results from a Longitudinal Follow-Up [J].
Antonelli, Alessandro ;
Fallahi, Poupak ;
Ferrari, Silvia Martina ;
Mancusi, Caterina ;
Giuggioli, Dilia ;
Colaci, Michele ;
Ferri, Clodoveo .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (07) :E1198-E1202
[9]   CXCL9 and CXCL11 Chemokines Modulation by Peroxisome Proliferator-Activated Receptor-α Agonists Secretion in Graves' and Normal Thyrocytes [J].
Antonelli, Alessandro ;
Ferrari, Silvia Martina ;
Frascerra, Silvia ;
Pupilli, Cinzia ;
Mancusi, Caterina ;
Metelli, Maria Rita ;
Orlando, Claudio ;
Ferrannini, Ele ;
Fallahi, Poupak .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (12) :E413-E420
[10]  
Barsotti S, 2016, CLIN EXP RHEUMATOL, V34, pS3